Dimetotiazine (INN) is a phenothiazine drug used for the treatment of migraine. It is a serotonin antagonist and histamine antagonist.[1]
Clinical data | |
---|---|
Other names | Dimethothiazine |
AHFS/Drugs.com | International Drug Names |
Routes of administration | By mouth |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.028.390 |
Chemical and physical data | |
Formula | C19H25N3O2S2 |
Molar mass | 391.55 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
References
edit- ^ Shimazawa M, Hara H, Watano T, Sukamoto T (August 1995). "Effects of Ca2 channel blockers on cortical hypoperfusion and expression of c-Fos-like immunoreactivity after cortical spreading depression in rats". British Journal of Pharmacology. 115 (8): 1359–68. doi:10.1111/j.1476-5381.1995.tb16624.x. PMC 1908864. PMID 8564192.1359-68&rft.date=1995-08&rft_id=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1908864#id-name=PMC&rft_id=info:pmid/8564192&rft_id=info:doi/10.1111/j.1476-5381.1995.tb16624.x&rft.aulast=Shimazawa&rft.aufirst=M&rft.au=Hara, H&rft.au=Watano, T&rft.au=Sukamoto, T&rft_id=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1908864&rfr_id=info:sid/en.wikipedia.org:Dimetotiazine" class="Z3988">